•
Sep 30, 2019

Voyager Therapeutics Q3 2019 Earnings Report

Total Revenue
$20.4M
Previous year: $2.09M
+875.8%
EPS
-$0.41
Previous year: -$0.63
-34.9%
Gross Profit
-$9.34M
Cash and Equivalents
$82.6M
Free Cash Flow
-$22.8M
Total Assets
$376M

Voyager Therapeutics

Voyager Therapeutics